Institutional & Family Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Institutional & Family Asset Management, LLC

$846 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$372.08 - $439.57 $17,859 - $21,099	-48 Reduced 97.96%	1 $0
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $1,343 - $1,612	-4 Reduced 7.55%	49 $18,000
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $16,738 - $20,870	53 New	53 $18,000

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

9.29M
Shares

$6.62 Billion
0.12% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$6.02 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

7.06M
Shares

$5.04 Billion
0.41% of portfolio
State Street Corp Boston, MA

4.83M
Shares

$3.45 Billion
0.14% of portfolio
Capital International Investors Los Angeles, CA

4.74M
Shares

$3.38 Billion
0.66% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.

Account